Approval · Notice of Compliance 9094 · 2007
ANDRODERM: Notice of Compliance 9094
Issued October 16, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9094
- Date
- October 16, 2007
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Androgens
Products in this notice
Medicinal ingredients
- TESTOSTERONE 12.2 MG per PATCH
- TESTOSTERONE 24.3 MG per PATCH